Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
31387004
DOI
10.1016/j.biopha.2019.109278
PII: S0753-3322(19)31179-5
Knihovny.cz E-zdroje
- Klíčová slova
- Combination therapy, Curcumin, Curcumin derivatives, Drug delivery system, Gastric cancer,
- MeSH
- biologické modely MeSH
- kurkumin chemie terapeutické užití MeSH
- lidé MeSH
- nádory žaludku farmakoterapie MeSH
- systémy cílené aplikace léků MeSH
- výsledek terapie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- kurkumin MeSH
Gastric cancer is a common oncological disease. Although enormous efforts have been expended, possible therapeutic modalities are still limited. For this reason, new therapeutic approaches and agents are highly requested and intensively developed. One strategy is the application of natural agents, such as curcumin, with proven anticancer effects and low toxicity for patients. Therefore, this review discusses the potential application of curcumin in the therapy of gastric cancer and its potential incorporation in therapeutic regimens. Because one of the largest impediments for widespread curcumin application is its limited bioavailability (caused mainly by its very low water solubility), studied strategies (drug delivery systems and curcumin derivatization) aimed to solve this obstacle are discussed in more detail.
BIOCEV 1st Faculty of Medicine Charles University Průmyslová 595 252 50 Vestec Czech Republic
Food Research Institute Prague Radiová 1285 7 1285 7 Prague 10 Czech Republic
Research and Development Center C2P s r o Jungmannova 101 503 51 Chlumec nad Cidlinou Czech Republic
Citace poskytuje Crossref.org
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer
Investigating antibacterial and anti-inflammatory properties of synthetic curcuminoids
Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design